IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells

Background: detailed information about circulating tumor cells (CTCs) as an indicator of therapy response and cancer metastasis is crucial not only for basic research but also for diagnostics and therapeutic approaches. Here, we showcase a newly developed IsoMAG IMS system with an optimized protocol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alena Gribko, Janis Stiefel, Lana Liebetanz, Sophie Madeleine Nagel, Julian Künzel, Madita Wandrey, Jan Hagemann, Roland H. Stauber, Christian Freese, Désirée Gül
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/530d9fbd81f045eba42d343f7ae680f5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:530d9fbd81f045eba42d343f7ae680f5
record_format dspace
spelling oai:doaj.org-article:530d9fbd81f045eba42d343f7ae680f52021-11-25T17:21:04ZIsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells10.3390/diagnostics111120402075-4418https://doaj.org/article/530d9fbd81f045eba42d343f7ae680f52021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2040https://doaj.org/toc/2075-4418Background: detailed information about circulating tumor cells (CTCs) as an indicator of therapy response and cancer metastasis is crucial not only for basic research but also for diagnostics and therapeutic approaches. Here, we showcase a newly developed IsoMAG IMS system with an optimized protocol for fully automated immunomagnetic enrichment of CTCs, also revealing rare CTC subpopulations. Methods: using different squamous cell carcinoma cell lines, we developed an isolation protocol exploiting highly efficient EpCAM-targeting magnetic beads for automated CTC enrichment by the IsoMAG IMS system. By FACS analysis, we analyzed white blood contamination usually preventing further downstream analysis of enriched cells. Results: 1 µm magnetic beads with tosyl-activated hydrophobic surface properties were found to be optimal for automated CTC enrichment. More than 86.5% and 95% of spiked cancer cells were recovered from both cell culture media or human blood employing our developed protocol. In addition, contamination with white blood cells was minimized to about 1200 cells starting from 7.5 mL blood. Finally, we showed that the system is applicable for HNSCC patient samples and characterized isolated CTCs by immunostaining using a panel of tumor markers. Conclusion: Herein, we demonstrate that the IsoMAG system allows the detection and isolation of CTCs from HNSCC patient blood for disease monitoring in a fully-automated process with a significant leukocyte count reduction. Future developments seek to integrate the IsoMAG IMS system into an automated microfluidic-based isolation workflow to further facilitate single CTC detection also in clinical routine.Alena GribkoJanis StiefelLana LiebetanzSophie Madeleine NagelJulian KünzelMadita WandreyJan HagemannRoland H. StauberChristian FreeseDésirée GülMDPI AGarticleautomationliquid biopsycirculating tumor cellshead and neck squamous cell carcinomaimmunomagnetic particle-based detectionmetastasisMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2040, p 2040 (2021)
institution DOAJ
collection DOAJ
language EN
topic automation
liquid biopsy
circulating tumor cells
head and neck squamous cell carcinoma
immunomagnetic particle-based detection
metastasis
Medicine (General)
R5-920
spellingShingle automation
liquid biopsy
circulating tumor cells
head and neck squamous cell carcinoma
immunomagnetic particle-based detection
metastasis
Medicine (General)
R5-920
Alena Gribko
Janis Stiefel
Lana Liebetanz
Sophie Madeleine Nagel
Julian Künzel
Madita Wandrey
Jan Hagemann
Roland H. Stauber
Christian Freese
Désirée Gül
IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
description Background: detailed information about circulating tumor cells (CTCs) as an indicator of therapy response and cancer metastasis is crucial not only for basic research but also for diagnostics and therapeutic approaches. Here, we showcase a newly developed IsoMAG IMS system with an optimized protocol for fully automated immunomagnetic enrichment of CTCs, also revealing rare CTC subpopulations. Methods: using different squamous cell carcinoma cell lines, we developed an isolation protocol exploiting highly efficient EpCAM-targeting magnetic beads for automated CTC enrichment by the IsoMAG IMS system. By FACS analysis, we analyzed white blood contamination usually preventing further downstream analysis of enriched cells. Results: 1 µm magnetic beads with tosyl-activated hydrophobic surface properties were found to be optimal for automated CTC enrichment. More than 86.5% and 95% of spiked cancer cells were recovered from both cell culture media or human blood employing our developed protocol. In addition, contamination with white blood cells was minimized to about 1200 cells starting from 7.5 mL blood. Finally, we showed that the system is applicable for HNSCC patient samples and characterized isolated CTCs by immunostaining using a panel of tumor markers. Conclusion: Herein, we demonstrate that the IsoMAG system allows the detection and isolation of CTCs from HNSCC patient blood for disease monitoring in a fully-automated process with a significant leukocyte count reduction. Future developments seek to integrate the IsoMAG IMS system into an automated microfluidic-based isolation workflow to further facilitate single CTC detection also in clinical routine.
format article
author Alena Gribko
Janis Stiefel
Lana Liebetanz
Sophie Madeleine Nagel
Julian Künzel
Madita Wandrey
Jan Hagemann
Roland H. Stauber
Christian Freese
Désirée Gül
author_facet Alena Gribko
Janis Stiefel
Lana Liebetanz
Sophie Madeleine Nagel
Julian Künzel
Madita Wandrey
Jan Hagemann
Roland H. Stauber
Christian Freese
Désirée Gül
author_sort Alena Gribko
title IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
title_short IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
title_full IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
title_fullStr IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
title_full_unstemmed IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
title_sort isomag—an automated system for the immunomagnetic isolation of squamous cell carcinoma-derived circulating tumor cells
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/530d9fbd81f045eba42d343f7ae680f5
work_keys_str_mv AT alenagribko isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT janisstiefel isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT lanaliebetanz isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT sophiemadeleinenagel isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT juliankunzel isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT maditawandrey isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT janhagemann isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT rolandhstauber isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT christianfreese isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
AT desireegul isomaganautomatedsystemfortheimmunomagneticisolationofsquamouscellcarcinomaderivedcirculatingtumorcells
_version_ 1718412470780952576